Abstract
Exposure of weanling rats to a diet containing 1% elemental tellurium causes segmental demyelination of peripheral nerve, and an inhibition of squalene epoxidase. This inhibition is thought to be the mechanism of action leading to demyelination. Tellurite appears to be the active inhibitory species in a cell-free system but the active species in vivo is unknown. We examined potassium tellurite (K2TeO3) and three organotellurium compounds for their ability to inhibit squalene epoxidase in Schwann cell cultures and to induce demyelination in weanling rats. K2TeO3 had no effect on squalene epoxidase activity in cultured Schwann cells and caused no demyelination in vivo. All three organotellurium compounds caused inhibition of squalene epoxidase in vitro and caused demyelination in vivo. (CH3)2TeCl2 was the most potent of these compounds and its neuropathy most resembled that caused by elemental tellurium. These data are consistent with the hypothesis that tellurium-induced demyelination is a result of squalene epoxidase inhibition and suggest that a dimethyltelluronium compound may be the neurotoxic species presented to Schwann cells in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Lampert, P., Garro, F., and Pentschew, A 1970. Tellurium neuropathy. Acta Neuropathol. (Berl) 15:308-317.
Lampert, P. W., and Garrett, R. S. 1971. Mechanism of demyelination in tellurium neuropathy. Electron microscopic observations. Lab. Invest. 25:380-388.
Miyoshi, K., and Takauchi, S. 1977. Chronic tellurium intoxication in rats. Folia Psychiatr. Neurol. Jpn. 31:111-118.
Duckett, S., Said, G., Streletz, L. G., White, R. G., and Galle, P. 1979. Tellurium-induced neuropathy: correlative physiological, morphological and electron microprobe studies. Neuropathol. Appl. Neurobiol. 5:265-178.
Said, G., Duckett, S., and Sauron, B. 1981. Proliferation of Schwann cells in tellurium-induced demyelination in young rats. A radioautographic and teased fiber study. Acta Neuropathol. (Berl.) 53:173-179.
Takahashi, T. 1981. Experimental study on segmental demyelination in tellurium neuropathy. Hokkaido Igaku. Zasshi. 56:105-131.
Wiley-Livingston, C. A., and Ellisman, M. H. 1982. Return of axonal and glial membrane specializations during remyelination after tellurium-induced demyelination. J. Neurocytol. 11:65-80.
Bouldin, T. W., Samsa, G., Earnhardt, T. S., and Krigman, M. R. 1988. Schwann cell vulnerability to demyelination is associated with internodal length in tellurium neuropathy. J. Neuropathol. Exp. Neurol. 47:41-47.
Toews, A. D., Goodrum, J. F., Lee, S. Y., Eckermann, C., and Morell, P. 1991. Tellurium-induced alterations in 3-hydroxy-3-methylglutaryl-CoA reductase gene expression and enzyme activity: differential effects in sciatic nerve and liver suggest tissue-specific regulation of cholesterol synthesis. J. Neurochem. 57:1902-1906.
Toews, A. D., Griffiths, I. R., Kyriakides, E., Goodrum, J. F., Eckermann, C. E. Morell, P., and Thomson, C. E. 1992. Primary demyelination induced by exposure to tellurium alters Schwanncell gene expression. A model for intracellular targeting of NGF receptor. J. Neuroscience 12:3676-3687.
Said, G., and Duckett, S. 1981. Tellurium-induced myelinopathy in adult rats. Muscle & Nerve 4:319-325.
Harry, G. J., Goodrum, J. F., Bouldin, T. W., Wagner-Recio, M., Toews, A. D., and Morell, P. 1989. Tellurium-induced neuropathy: metabolic alterations associated with demyelination and remyelination in rat sciatic nerve. J. Neurochem. 52:938-945.
Goodrum, J. F., Earnhardt, T. S., Goines, N. D., and Bouldin, T. W. 1990. Lipid droplets in Schwann cells during tellurium neuropathy are derived from newly synthesized lipid. J. Neurochem. 55:1928-1932.
Wagner-Recio, M., Toews, A. D., and Morell, P. 1991. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: preferential vulnerability to this metabolic block leads to peripheral nervous system demyelination. J. Neurochem. 57:1891-1901.
Wagner, M., Toews, A. D., and Morell, P. 1995. Tellurite specifically affects squalene epoxidase: investigations examining the mechanism of tellurium-induced neuropathy. J. Neurochem. 64:2169-2176.
Morell, P. 1994. Biochemical and molecular bases of myelinopathy. Pages 583-608, in Chang, L.W. (ed.), Principles of Neurotoxicology, Marcel Dekker, Inc., New York.
Braheny, S. L., and Lampert, P. W. 1980. Tellurium. Pages 558-569, in Spencer, P.S., and Schaumburg, H.H. (eds.), Experimental and Clinical Neurotoxicology, Williams and Wilkins, Baltimore.
Neuberger, T. J., Kalimi, O., Regelson, W., Kalimi, M., and DeVries, G. 1994. Glucocoritcoids enhance the potency of Schwann cell mitogens. J. Neurosci. Res. 38:300-313.
Brockes, J. P., Fields, K. L., and Raff, M. C. 1979. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerves. Brain Res. 165:105-118.
Turner, R. J., Weiner, J. H., and Taylor, D. E. 1992. Use of diethyldithiocarbamate for quantitative determination of tellurite uptake by bacteria. Analyt. Biochem. 204:292-295.
Amdur, M. L. 1947. Tellurium: accidental exposure and treatment with BAL in oil. Occup. Med. 3:386-391.
Fishbein, L. 1977. Toxicology of selenium and tellurium. Pages 191-240, in Goyer, R. A., and Mehlman, M. A. (eds.), Advances in Modern Toxicology Vol. II., John Wiley & Sons, New York.
De Meio, R. H. 1946. Tellurium I. The toxicity of ingested elementary tellurium for rats and rat tissues. J. Indust. Hyg. Toxicol. 28:299-304.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goodrum, J.F. Role of Organotellurium Species in Tellurium Neuropathy. Neurochem Res 23, 1313–1319 (1998). https://doi.org/10.1023/A:1020704502586
Issue Date:
DOI: https://doi.org/10.1023/A:1020704502586